Cargando…
Overview of the current promising approaches for the development of an effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine
Coronavirus disease 2019 (COVID-19) is a pandemic infectious disease caused by the novel coronavirus called SARS-CoV-2. There is a gap in our understanding regarding the immunopathogenesis of COVID-19. However, many clinical trials are underway across the world for screening effective drugs against...
Autores principales: | Mirzaei, Rasoul, Mohammadzadeh, Rokhsareh, Mahdavi, Farzad, Badrzadeh, Fariba, Kazemi, Sheida, Ebrahimi, Mehdi, Soltani, Fatemeh, Kazemi, Sima, Jeda, Ali Salimi, Darvishmotevalli, Mohammad, Yousefimashouf, Rasoul, Keyvani, Hossein, Karampoor, Sajad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444935/ https://www.ncbi.nlm.nih.gov/pubmed/32862110 http://dx.doi.org/10.1016/j.intimp.2020.106928 |
Ejemplares similares
-
The emerging role of microRNAs in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection
por: Mirzaei, Rasoul, et al.
Publicado: (2021) -
The emerging role of probiotics as a mitigation strategy against coronavirus disease 2019 (COVID-19)
por: Mirzaei, Rasoul, et al.
Publicado: (2021) -
Correction to: The emerging role of probiotics as a mitigation strategy against coronavirus disease 2019 (COVID‑19)
por: Mirzaei, Rasoul, et al.
Publicado: (2021) -
microRNAs in human brucellosis: A promising therapeutic approach and biomarker for diagnosis and treatment
por: Kazemi, Sima, et al.
Publicado: (2021) -
Coronavirus disease 2019 (COVID-19): Immunological approaches and emerging pharmacologic treatments
por: Goodarzi, Pedram, et al.
Publicado: (2020)